SKYRIZI® (Risankizumab-rzaa) Pen
The SKYRIZI® (Risankizumab-rzaa) Pen, developed by AbbVie, is a prescription medicine approved for the treatment of adults with active Psoriatic Arthritis (PsA)
The SKYRIZI® (Risankizumab-rzaa) Pen, developed by AbbVie, is a prescription medicine approved for the treatment of adults with active Psoriatic Arthritis (PsA). The pen features an easy to grip device with a removable cap, self-retracting needle and a clear window for visible notification when administration is complete.Learn more about SKYRIZI here
Ease of Use Program
Products Proven to Make Life Easier
The Arthritis Foundation's Ease of Use Certification Program recognizes products proven to make life easier for people who have arthritis and other physical limitations. Independently tested by experts and evaluated by people with arthritis, Ease of Use products are easy to use for everyone.
Learn More About the Ease of Use Program
Stay in the Know. Live in the Yes.
Get involved with the arthritis community. Tell us a little about yourself and, based on your interests, you’ll receive emails packed with the latest information and resources to live your best life and connect with others.